Daily risedronate prevents bone loss in osteopenic, postmenopausal women:: A 2-year multicenter trial in europe

被引：0
|
作者：
Valmaki, M. [1 ]
Heikkinen, J. [2 ]
Munoz-Torres, M. [3 ]
Mulder, H. [4 ]
Ofjord, E. S. [5 ]
Toss, G. [6 ]
机构：
[1] Univ Helsinki, Cent Hosp, Div Endocrinol, FIN-00014 Helsinki, Finland
[2] Deaconess Inst Oulu, Osteoporosis Clin, Oulu, Finland
[3] Hosp Clin San Cecilio, Granada, Spain
[4] Osteosupport, Rotterdam, Netherlands
[5] Linkoping Univ Hosp, Dept Endocrinol, S-58185 Linkoping, Sweden
[6] Ctr Clin Studies AS, Paradis, Norway
来源：
OSTEOPOROSIS INTERNATIONAL | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S60 / S61
页数：2
相关论文
共 50 条
  • [41] ASSOCIATION BETWEEN MARKERS OF BONE LOSS AND URINARY LITHOGENIC RISK FACTORS IN OSTEOPENIC POSTMENOPAUSAL WOMEN
    Granchi, D.
    Caudarella, R.
    Ripamonti, C.
    Spinnato, P.
    Bazzocchi, A.
    Torreggiani, E.
    Massa, A.
    Baldini, N.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2016, 30 (04): : 145 - 151
  • [42] Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate
    Gamsjaeger, Sonja
    Buchinger, Birgit
    Zoehrer, Ruth
    Phipps, Roger
    Klaushofer, Klaus
    Paschalis, Eleftherios P.
    [J]. BONE, 2011, 49 (06) : 1160 - 1165
  • [43] EFFECT OF TWO DIFFERENT THERAPEUTIC REGIMENS OF CLODRONATE ON BONE MINERAL DENSITY IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS: A 2-YEAR RANDOMIZED TRIAL
    Giusti, A.
    Girasole, G.
    Garzia, V.
    Siccardi, V.
    Locaputo, A.
    Diana, P.
    Ponte, M.
    Bianchi, G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S260 - S260
  • [44] Alendronate prevents postmenopausal bone loss in women without osteoporosis - A double-blind, randomized, controlled trial
    McClung, M
    Clemmesen, B
    Daifotis, A
    Gilchrist, NL
    Eisman, J
    Weinstein, RS
    El-Hajj Fuleihan, G
    Reda, C
    Yates, AJ
    Ravn, P
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 128 (04) : 253 - +
  • [45] Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study
    M. Atteritano
    S. Mazzaferro
    A. Bitto
    M. L. Cannata
    R. D’Anna
    F. Squadrito
    I. Macrì
    A. Frisina
    N. Frisina
    G. Bagnato
    [J]. Osteoporosis International, 2014, 25 : 1123 - 1129
  • [46] Risedronate reverses bone loss in postmenopausal women with low bone mass: Results from a multinational, double-blind, placebo-controlled trial
    Fogelman, I
    Ribot, C
    Smith, R
    Ethgen, D
    Sod, E
    Reginster, JY
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (05): : 1895 - 1900
  • [47] PREVENTION OF POSTMENOPAUSAL BONE LOSS IN RHEUMATOID-ARTHRITIS PATIENTS - A 2-YEAR PROSPECTIVE-STUDY
    VERSTRAETEN, A
    DEQUEKER, J
    NIJS, J
    GEUSENS, P
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1989, 7 (04) : 351 - 358
  • [48] Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study
    Atteritano, M.
    Mazzaferro, S.
    Bitto, A.
    Cannata, M. L.
    D'Anna, R.
    Squadrito, F.
    Macri, I.
    Frisina, A.
    Frisina, N.
    Bagnato, G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 (03) : 1123 - 1129
  • [49] Letter to the Editor: "Dietary Calcium Intake and Bone Loss Over 6 Years in Osteopenic Postmenopausal Women"
    Pazianas, Michael
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (09): : 3609 - 3609
  • [50] Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: A 2-year placebo-controlled trial
    Arrenbrecht, S
    Boermans, AJM
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13 (02) : 176 - 183
12345